The IRF transcription factor family in type I interferon-mediated antiviral immunity and associated diseases
Open Access
- 6 January 2026
- journal article
- review article
- Published by Springer Nature in Immunity & Inflammation
- Vol. 2 (1) , 1
Abstract
No abstract availableKeywords
Funding Information
- Takeda Science Foundation
- Astellas Foundation for Research on Metabolic Disorders
- Daiichi Sankyo Foundation of Life Science
- Chugai Foundation for Innovative Drug Discovery Science
- Ministry of Education, Culture, Sports, Science and Technology (24H00606)
This publication has 251 references indexed in Scilit:
- SARS‐CoV‐2 NSP13 interacts with host IRF3, blocking antiviral immune responsesJournal of Medical Virology, 2023
- Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk LocusArthritis & Rheumatology, 2023
- Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasionJournal of Medical Virology, 2023
- Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferonsArthritis & Rheumatism, 2011
- Association of a functional IRF7 variant with systemic lupus erythematosusArthritis & Rheumatism, 2010
- Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon‐α activity in lupus patientsArthritis & Rheumatism, 2010
- Genetic variants and disease‐associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosusArthritis & Rheumatism, 2010
- Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patientsArthritis & Rheumatism, 2008
- Kaposi Sarcoma Herpesvirus-Encoded Interferon Regulator Factors2006
- TLR4 as the Mammalian Endotoxin Sensor2002